Anti-PD-1 therapy for clinical treatment of lymphoma: a single-arm meta-analysis

Anti-PD1 antibodies exhibit satisfactory efficacy in treating certain types of lymphoma. We conducted this meta-analysis to explore subtypes benefiting from this treatment and the best anti-PD1 therapeutic modalities. METHODS: A quantitative meta-analysis was performed via a systematic search in Pub...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Zhe, Xiao, Yi, Zhu, Xiao-Jian, Ye, Cong, Zhou, Jian-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219677/
https://www.ncbi.nlm.nih.gov/pubmed/30450162
http://dx.doi.org/10.18632/oncotarget.26223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219677/
https://www.ncbi.nlm.nih.gov/pubmed/30450162
http://dx.doi.org/10.18632/oncotarget.26223

Ejemplares similares